Seattle Children’s Launches 2-Pronged CAR T-Cell Therapy Trial in Refractory Acute Lymphoblastic Leukemia – Immuno-Oncology News
|
Seattle Children’s Launches 2-Pronged CAR T-Cell Therapy Trial in Refractory Acute Lymphoblastic Leukemia
Immuno-Oncology News Seattle Children’s Hospital has launched a new clinical trial, PLAT-05 (NCT03330691), and is currently recruiting participants to test a new CAR T-cell immunotherapy targeting two proteins expressed on cancer cells of certain patients with relapsed or … |
Gizmodo |
The Feds Are Officially Cracking Down on Basement Biohackers
Gizmodo The Food and Drug Agency has issued a stern warning to anyone who might be crazy enough to undertake gene therapy in the do-it-yourself fashion. Definitely don’t do this at home, a statement released on Tuesday implies. And if you do, we’ll throw every … |
Boston Business Journal |
FDA warns against ‘do it yourself’ gene therapy kits
Boston Business Journal The U.S. Food and Drug Administration has issued a stern warning against the use of “do it yourself” gene therapy kits, pushing back against a nascent “biohacker” movement that seeks to make experimental medicines and technologies available to the … |
|
George Yohrling of HDSA on Immunotherapy in Huntington’s Disease
Rare Disease Report George Yohrling of HDSA on Immunotherapy in Huntington’s Disease. NOVEMBER 22, 2017. Mathew Shanley. George Yohrling, PhD, has served as the Senior Director, Mission and Scientific Affairs for the Huntington’s Disease Society of America (HDSA) … |